Ryan N, Anderson K, Volpedo G, Varikuti S, Satoskar M, Satoskar S, Oghumu S. The IL-33/ST2 axis in immune responses against parasitic disease: potential therapeutic applications. Front Cell Infect Microbiol. 2020;10:153. https://doi.org/10.3389/fcimb.2020.00153.
Article
CAS
PubMed
PubMed Central
Google Scholar
Di Salvo E, Ventura-Spagnolo E, Casciaro M, Gangemi s. IL-33/IL-31 axis: a potential inflammatory pathway. Mediators Inflamm. 2018. https://doi.org/10.1155/2018/3858032.
Article
PubMed
PubMed Central
Google Scholar
Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007;179(4):2551–5. https://doi.org/10.4049/jimmunol.179.4.2551.
Article
CAS
PubMed
Google Scholar
Cayrol C, Girard JP. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev. 2018;281(1):154–68. https://doi.org/10.1111/imr.12619.
Article
CAS
PubMed
Google Scholar
Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A. 2007;104(47):18660–5. https://doi.org/10.1073/pnas.0705939104.
Article
PubMed
PubMed Central
Google Scholar
Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, Girard JP. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol. 2012;188(7):3488–95. https://doi.org/10.4049/jimmunol.1101977.
Article
CAS
PubMed
Google Scholar
Molofsky AB, Van Gool F, Liang HE, Van Dyken SJ, Nussbaum JC, Lee J, Bluestone JA, Locksley RM. Interleukin-33 and Interferon-γ counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity. 2015;43(1):161–74. https://doi.org/10.1016/j.immuni.2015.05.019.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A. 2007;104(1):282–7. https://doi.org/10.1073/pnas.0606854104.
Article
CAS
PubMed
Google Scholar
Choi YS, Park JA, Kim J, Rho SS, Park H, Kim YM, Kwon YG. Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation. Biochem Biophys Res Commun. 2012;421(2):305–11. https://doi.org/10.1016/j.bbrc.2012.04.005.
Article
CAS
PubMed
Google Scholar
Stier MT, Mitra R, Nyhoff LE, Goleniewska K, Zhang J, Puccetti MV, Casanova HC, Seegmiller AC, Newcomb DC, Kendall PL, Eischen CM, Peebles RS Jr. IL-33 Is a cell-intrinsic regulator of fitness during early B cell development. J Immunol. 2019;203(6):1457–67.
Article
CAS
Google Scholar
Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, De Angelis PM, Scott H, Haraldsen G. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol. 2008;173(4):1229–42. https://doi.org/10.2353/ajpath.2008.080014.
Article
CAS
PubMed
PubMed Central
Google Scholar
Casciaro M, Cardia R, Di Salvo E, Tuccari G, Ieni A, Gangemi S. Interleukin-33 involvement in nonsmall cell lung carcinomas: an update. Biomolecules. 2019;9(5):203. https://doi.org/10.3390/biom9050203.
Article
CAS
PubMed Central
Google Scholar
Johnston LK, Chien KB, Bryce PJ. The immunology of food allergy. J Immunol. 2014;15(6):2529–34.
Article
Google Scholar
Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33:245–54. https://doi.org/10.1038/ng1089.
Article
CAS
PubMed
Google Scholar
Krajewski D, Kaczenski E, Rovatti J, Polukort S, Thompson C, Dollard C, Ser-Dolansky J, Schneider SS, Kinney SRM, Mathias CB. Epigenetic regulation via altered histone acetylation results in suppression of mast cell function and mast cell-mediated food allergic responses. Front Immunol. 2018;9:2414. https://doi.org/10.3389/fimmu.2018.02414.
Article
CAS
PubMed
PubMed Central
Google Scholar
Che DN, Cho BO, Kim J-S, Shin JY, Kang HJ, Jang SI. Effect of Luteolin and apigenin on the production of Il-31 and Il-33 in lipopolysaccharides-activated microglia cells and their mechanism of action. Nutrients. 2020;12(3):811. https://doi.org/10.3390/nu12030811.
Article
CAS
PubMed Central
Google Scholar
Liu L, Mao L, Wu X, Wu T, Liu W, Yang Y, Zhang T, Xu Y. BRG1 regulates endothelial-derived IL-33 to promote ischemia-reperfusion induced renal injury and fibrosis in mice. Biochim Biophys Acta Mol Basis Dis. 2019;1865:2551–61. https://doi.org/10.1016/j.bbadis.2019.06.015.
Article
CAS
PubMed
Google Scholar
Zhang F, Tossberg JT, Spurlock CF, Yao SY, Aune TM, Sriram S. Expression of IL-33 and its epigenetic regulation in Multiple Sclerosis. Ann Clin Transl Neurol. 2014;1(5):307–18. https://doi.org/10.1002/acn3.47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sriram S, Shaginurova G, Tossberg JT, Natarajan C, Iii CFS, Aune TM. Longitudinal changes in the expression of IL-33 and IL-33 regulated genes in relapsing remitting MS. PLoS ONE. 2018;13(12):e0208755. https://doi.org/10.1371/journal.pone.0208755.
Article
PubMed
PubMed Central
Google Scholar
Holmes DA, Yeh JH, Yan D, Xu M, Chan AC. Dusp5 negatively regulates IL-33-mediated eosinophil survival and function. EMBO J. 2015;34(2):218–35. https://doi.org/10.15252/embj.201489456.
Article
CAS
PubMed
Google Scholar
Umebashi K, Tokito A, Yamamoto M, Jougasaki M. Interleukin-33 induces interleukin-8 expression via JNK/c-Jun/AP-1 pathway in human umbilical vein endothelial cells. PLOS ONE. 2018;13(1):e0191659.
Article
Google Scholar
Goh FY, Cook KLTP, Upton N, Tao L, Lah LC, Leung BP, Wong WSF. Receptor-interacting protein 2 gene silencing attenuates allergic airway inflammation. J Immunol. 2013;191(5):2691–9. https://doi.org/10.4049/jimmunol.1202416.
Article
CAS
PubMed
Google Scholar
He D-K, Xu N, Shao Y-R, Shen J. NLRP3 gene silencing ameliorates phosgene-induced acute lung injury in rats by inhibiting NLRP3 inflammasome and proinflammatory factors, but not anti-inflammatory factors. J Toxicol Sci. 2020;45:625–37. https://doi.org/10.2131/jts.45.625.
Article
CAS
PubMed
Google Scholar
Lau SF, Chen C, Fu WY, Qu JY, Cheung TH, Fu AKY, Ip NY. IL-33-PU.1 Transcriptome reprogramming drives functional state transition and clearance activity of microglia in Alzheimer’s disease. Cell Rep. 2020;31(3):107530.
Article
CAS
Google Scholar
Pishdadian A, Varasteh A, Gholamin M, Nasiraie LR, Hosseinpour M, Moghadam M, Sankian M. Lung-derived innate cytokines: new epigenetic targets of allergen-specific sublingual immunotherapy. Iran J Basic Med Sci. 2016;19:64–71.
PubMed
PubMed Central
Google Scholar
Rui T, Tang Q. IL-33 attenuates anoxia/reoxygenation-induced cardiomyocyte apoptosis by inhibition of PKCβ/JNK pathway. PLOS ONE. 2013;8(2):e56089. https://doi.org/10.1371/journal.pone.0056089.
Article
CAS
PubMed
PubMed Central
Google Scholar